Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

BioNTech inaugurates first manufacturing plant for mRNA vaccines in Rwanda

STORY: BioNTech inaugurates first manufacturing plant for mRNA vaccines in Rwanda SHOOTING TIME: Dec. 18, 2023 DATELINE: Dec. 21, 2023 LENGTH: 0:02:34 LOCATION: Kigali CATEGORY: TECHNOLOGY/ECONOMY SHOTLIST: 1. various of the event 2. SOUNDBITES 1 (English) UGUR SAHIN, Co-founder and CEO of BioNTech 3. SOUNDBITES 2 (English) MOUSSA FAKI MAHAMAT, Chairperson of the African Union (AU) Commission STORYLINE: BioNTech, a leading biotechnology company, on Monday inaugurated its first manufacturing plant for mRNA vaccines in Africa in Rwanda's capital of Kigali. The inauguration comes after the German company signed deals in 2021 with Rwanda and the Institut Pasteur de Dakar in Senegal to set up manufacturing sites on the continent. The facility construction was launched last year. BioNTech indicated in a statement that it is on course to develop prophylactic mRNA vaccines targeting infectious diseases such as tuberculosis, malaria, and HIV, and is also focusing on diseases with epidemic and pandemic potential,

E

Nobel laureate Kariko underscores groundbreaking potential of mRNA technology

STORY: Nobel laureate Kariko underscores groundbreaking potential of mRNA technology DATELINE: Oct. 15, 2023 LENGTH: 00:01:32 LOCATION: SZEGED, Hungary CATEGORY: SCIENCE SHOTLIST: 1. various of the panel discussion STORYLINE: Biochemist Katalin Kariko, 2023 Nobel laureate in physiology or medicine, underscored the application potential of mRNA technology in a panel discussion at her alma mater, University of Szeged, on Thursday evening. Originally focused on cancer vaccines, mRNA's versatility has broadened to encompass various therapeutic applications, particularly in the rapidly evolving field of therapy drugs, she explained to an audience made up mostly of university students in response to a question from Xinhua. "Definitely, the messenger RNA (mRNA) as a therapy will be used for many, many applications, many different treatments, and therapies," she said. "Originally, you know the first ones of these companies such as BioNtech in 2008 were formed to make cancer vaccines, and they gained a lot of kn

E

Illustration: BioNTech

SUQIAN, CHINA - JUNE 11, 2023 - Illustration: BioNTech, Suqian, Jiangsu Province, China, June 11, 2023. BioNTech has been hit with 150,000 in Germany's first lawsuit over the side effects of its coronavirus vaccine.

E

Illustration: BioNTech

SUQIAN, CHINA - JUNE 11, 2023 - Illustration: BioNTech, Suqian, Jiangsu Province, China, June 11, 2023. BioNTech has been hit with 150,000 in Germany's first lawsuit over the side effects of its coronavirus vaccine.

E

Illustration: BioNTech

SUQIAN, CHINA - JUNE 11, 2023 - Illustration: BioNTech, Suqian, Jiangsu Province, China, June 11, 2023. BioNTech has been hit with 150,000 in Germany's first lawsuit over the side effects of its coronavirus vaccine.

E

Illustration: BioNTech

SUQIAN, CHINA - JUNE 11, 2023 - Illustration: BioNTech, Suqian, Jiangsu Province, China, June 11, 2023. BioNTech has been hit with 150,000 in Germany's first lawsuit over the side effects of its coronavirus vaccine.

E

Spanish Hipra vaccine to test its fourth dose

STORY: Spanish Hipra vaccine to test its fourth dose DATELINE: Sept. 1, 2022 LENGTH: 00:01:34 LOCATION: Madrid CATEGORY: HEALTH SHOTLIST: 1. various of HIPRA Laboratories 2. various of people at hospital STORYLINE: The Spanish pharmaceutical company HIPRA has announced that it will start a clinical trial in 10 hospitals at the end of this summer to study the effectiveness of its vaccine as a possible fourth dose to protect against COVID-19. Each of the 10 hospitals will test 200 volunteers, who have previously received 3 doses of a different vaccine (such as Pfizer-BioNTech), to discover the immune response and evaluate the safety of the HYPRA vaccine as a second 'booster' dose. The HYPRA vaccine is currently pending approval by the European Medicines Agency (EMA) in order to be marketed. The hospitals will start the trial once permission has been received from the Spanish Agency for Medicines and Health Products (AEMPS) and the Ethics Committee for Research with Medicines of the Hospital Clinic d

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

Secondary level students at a local school in Nepali capital Kathmandu display their vaccination card after being administered with dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu presses the point of injection after being administered with dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

Secondary level students of a local school in Nepali capital Kathmandu hold the point of injecture while they take rest after being administered with dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

07000000-HTH- NEPAL- KATHMANDU- PAEDIATRIC VACCINE ROLL OUT

A secondary level student at a local school in Nepali capital Kathmandu reacts while a paramedic admisters dosage of Pfizer-BioNTech manufactured anti-COVID vaccine. Nepal from 23rd June has rolled out vaccination campaign targeting the population (especially students) aged between 5 years to 12 years with the US donated paediatric vaccines.

E

BioNTech Senior Vice President Katalin Kariko

Katalin Kariko, senior vice president of BioNTech SE, gives an interview in Tokyo on April 15, 2022.

E

Japan Prize laureates meet with PM Kishida

Japanese Prime Minister Fumio Kishida (C) poses for a photo with Japan Prize laureates, including Katalin Kariko (3rd from R), senior vice president at BioNTech SE, at his office in Tokyo on April 15, 2022. The Japan Prize is awarded annually to scientists and engineers from around the world who have made significant contributions to the advancement of science and technology.

E

Japan Prize laureates meet with PM Kishida

Japanese Prime Minister Fumio Kishida (far L) meets with Japan Prize laureates, including Katalin Kariko (2nd from R), senior vice president at BioNTech SE, at his office in Tokyo on April 15, 2022. The Japan Prize is awarded annually to scientists and engineers from around the world who have made significant contributions to the advancement of science and technology.

E

Japan Prize award ceremony

Katalin Kariko, senior vice president at BioNTech SE, poses for photos at an award ceremony in Tokyo on April 13, 2022, after she won the Japan Prize for pioneering research contributing to the development of mRNA COVID-19 vaccines. (Pool photo)

E

Japan Prize award ceremony

Katalin Kariko, senior vice president at BioNTech SE, addresses an award ceremony in Tokyo on April 13, 2022, after she won the Japan Prize for pioneering research contributing to the development of mRNA COVID-19 vaccines. (Pool photo)

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A nurse gets a dose of the Pfizer BioNTech COVID-19 Vaccine vial as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A nurse gets a dose of the Pfizer BioNTech COVID-19 Vaccine vial as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

People wait in chairs using protective face masks as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

People wait in chairs using protective face masks as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Covid-19 Vaccination In Colombia

A person gets a dose of the Pfizer BioNTech COVID-19 Vaccine as teenagers above the age of 12 get vaccinated against the novel COVID-19 disease with the Pfizer BioNTech and AstraZeneca Coronavirus vaccines, in Bogota, Colombia on October 19, 2021. Colombia aims to ease face mask use after 75% of the population are fully vaccinated. Photo by Martin Galindo/Long Visual Press/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A health worker shows a dose of Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A woman receives a dose of Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A man receives a dose of Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A man receives a dose of Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A health worker prepares a dose Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A health worker prepares a dose Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A Militar prepares a dose Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Mass Vaccination Campaign In Tunisia - Bizerte

A girl receives a dose of Pfizer-BioNTech during a mass campaign to vaccinate people against Covid-19 disease and reduce risk of infection. More than 460,000 people vaccinated during the 3rd national mass vaccination day against the coronavirus, According to the results of the 3rd national day of mass vaccination against the coronavirus, 467,631 people had their first dose of vaccine. Bizerte, Tunisia, August 29, 2021. Photo by Hasan Mrad/Eyepix/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

A nurse holds a vial of the Pfizer BioNtech COVID-19 vaccine during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

A biohazard waste filled with syringes during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

A child hugs her mother as she gets vaccinated against COVID-19 during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

Two health staff workers poses for a photo with a banner of self care against COVID-19 during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

A nurse gets a dose out of a Anti-Flu vaccine during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

A nurse that applies vaccines poses for a portrait during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM

E

Children Vaccinate Against Covid-19 And Common Diseases - Colombia

A teenager gets vaccinated with the Pfizer BioNtech COVID-19 Vaccine during a vaccination day inviting mothers and minors over the age of 12 to vaccinate against COVID-19 with the Pfizer BioNtech Coronavirus vaccine and children below the age of 10 to get vaccinated with basic vaccines (Anti-Flu, Rubella and measles) in Bogota, Colombia on August, 28, 2021. Photo by Chepa Beltran/Long Visual Press/ABACAPRESS.COM